CapsoVision (CV) FCF Margin (2024 - 2025)
CapsoVision's (CV) quarterly FCF Margin came in at 196.38% in Q4 2025, down 3997.0% year-over-year from 5.04% in Q4 2024, and down 22.36% quarter-over-quarter from 160.49% in Q3 2025.
Powered by 
Analysis
CapsoVision (CV) FCF Margin (2024 - 2025) Analysis & Trends
CapsoVision has disclosed FCF Margin across 2 years of filings, most recently posting 196.38% for Q4 2025.
- In Q4 2025, FCF Margin fell 3997.0% year-over-year to 196.38%; the TTM figure through Dec 2025 stood at 181.61% (changed N/A YoY), while the FY2025 annual figure was 169.35%, up 285.0% from the prior year.
- FCF Margin came in at 196.38% for Q4 2025 at CapsoVision, down from 160.49% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 156.4% in Q4 2024 to a low of 238.03% in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.54 Bn | 27.44 Bn | 2.18 Bn | 1.28% |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 23.15% |
| 3 | Heartflow | 4.04 Bn | 3.66 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.59 Bn | 2.41 Bn | 107.80 Mn | 11.63% |
| 5 | Butterfly Network | 1.96 Bn | 1.84 Bn | 23.29 Mn | -52.87% |
| 6 | Ceribell | 928.74 Mn | 799.48 Mn | 25.94 Mn | -45.84% |
| 7 | QuidelOrtho | 866.04 Mn | 742.64 Mn | - | - |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | 5.70% |
| 9 | Prenetics Global | 339.99 Mn | 280.94 Mn | 30.20 Mn | -44.43% |
| 10 | CapsoVision | 318.60 Mn | 309.52 Mn | 1.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -196.38% |
| Sep 30, 2025 | -160.49% |
| Dec 31, 2024 | -156.40% |
| Sep 30, 2024 | -238.03% |